Today on DrugResearcher.com   GSK cut down by Avandia scare Sanofi slammed by FDA over failure to act on Ketek fraud Illumina's revenue soars as Affymetrix sues again Personalised medicine leaves public cold Drugs moving into the clinic: 32

Related Industry News   Pharmaceutical patent round-up BioSPM drives JPK into 'Technology Fast 50' Sigma-Aldrich set to break $2bn yearly sales barrier MannKind all but shuts the door on Pfizer

Breaking News on Drug Discovery
Daily  Thursday 25 October 2007		Forward to a colleague

	Product Brochure High precision optical profiling of liquid drops enhances drug discovery Whether you are characterizing the uptake of active drug substances or controlling the quality of packaging materials, contact angle provides a quick, easy and sensitive measure of quality and cleanliness in research, QC and process control... Click Here Access Full Stories GSK cut down by Avandia scare GlaxoSmithKline (GSK) has emerged as the latest pharma firm to announce closures and job cuts along with its third quarter results, yet another casualty of generic competition and product safety scares... Read Sanofi slammed by FDA over failure to act on Ketek fraud The US Food and Drug Administration (FDA) has slammed Sanofi-Aventis over its failure to act on known instances of fraud during clinical trials of its antibiotic Ketek (telithromycin) - accusations that the firm... Read Illumina's revenue soars as Affymetrix sues again Illumina's third quarter revenues soared 82 per cent while Affymetrix looked to bolster its slice of the genetics market by filing more patent infringement claims against the young pretender... Read Personalised medicine leaves public cold For some people, the promise of personalised medicine just means more worry and potential stigmatisation and they'd simply rather not know if they are genetically susceptible to a certain disease, such as cancer... Read Drugs moving into the clinic: 32 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read
	All News Headlines for: October | September | August
	Product Brochure Have you got problems with aching hands in your lab? Lab professionals have twice as much upper limb disorders (URLD) as employees in general. The risk of Repetitive Strain Injury (RSI) increases, when pipetting over 1.5 hours/day. The strain will also have a negative impact on the accuracy and precision. Read more..... Click Here
	Related Industry News Pharmaceutical patent round-up In-PharmaTechnologist.com brings you an update of pharmaceutical patent litigations... Read BioSPM drives JPK into 'Technology Fast 50' Scanning probe microscope (SPM) maker, JPK Instruments has been named as Germany's fastest growing nanotechnology company in accounting firm Deloitte's 'Technology Fast 50'... Read Sigma-Aldrich set to break $2bn yearly sales barrier Sigma-Aldrich continued its strong year with both revenues and pre-tax profits showing strong double-digit growth in the third quarter predicting it will break the $2bn (€1.4bn) revenue mark this year... Read MannKind all but shuts the door on Pfizer MannKind Corporation needs an outside boost to get its inhaled insulin off the ground, but the likelihood of that partner being Pfizer is a 'very long shot', the president of the company says... Read Weekly Comment 'We are not anti-Asia' says EU chemicals body There have been more calls this month to tighten regulations on pharmaceutical ingredient suppliers in the wake of the recent safety concerns emanating from low-cost regions such as China and India.  However, despite having recently established a dedicated 'China Taskforce', a major EU chemicals consortium insists that it has nothing against the region or its manufacturers. Read Previous Headlines Merck KGaA pulls out of diabetes research In a shock announcement at its third quarter financial results, Merck KGaA has said it will stop its diabetes research and partner out any current programmes... Read Pfizer's cost-cutting focus no 'Kindler surprise' As it faces an increasingly uncertain financial future, Pfizer's reaffirmation that it plans to retain its focus on cutting costs, including outsourcing and offshoring, comes as no 'Kindler surprise', unlike the... Read J&J, Galapagos sign deal to search for arthritis 'Holy Grail' Belgian biotech Galapagos has penned 'by far' its biggest ever deal, with Johnson & Johnson (J&J) committing an estimated €1bn to a joint arthritis research programme... Read Microfluidic stimulation of cells in culture US researchers have developed a fully automated microfluidic cell culture system that can control signalling agents in the extracellular media while maintaining cell viability for weeks... Read Pfizer not alone in feeling the heat of California fires As the fires in California continue to rage, Pfizer and other pharma and biotech companies all over Southern California are bracing themselves for closures and even evacuations of their facilities... Read Technical / White Papers, Case studies, Web casts Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers Benefits of integrating human tissue research in drug discovery - Company Profile DAICEL chiral chromatography products - Company Profile Rapid HPLC method development with ChromSword®Auto software - Product Presentation Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com